Sellas Life Sciences Group Inc (NASDAQ:SLS) shares are trading lower by 35.7% to $0.58 Thursday afternoon. The stock is trading lower after the company announced pricing of a $9 million public offering.
What Else?
The 12 million shares of common stock along with accompanying warrants aims to generate $9 million before expenses.
Priced at $0.75 per share and warrant, these securities will grant the option to purchase an equal number of shares at the same price within five years.
A.G.P./Alliance Global Partners is the exclusive placement agent for this offering, set to conclude around January 8, pending standard closing conditions.
See Also: December Jobs Report Preview
According to data from Benzinga Pro, SLS has a 52-week high of $4.13 and a 52-week low of $0.58.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
